<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="161257">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01652495</url>
  </required_header>
  <id_info>
    <org_study_id>2012-000866-40</org_study_id>
    <nct_id>NCT01652495</nct_id>
  </id_info>
  <brief_title>Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to Corticosteroids Intrabursal Injection</brief_title>
  <acronym>TPESP2011-12</acronym>
  <official_title>Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to a Single Intrabursal Injection of Corticosteroids in Patients With Shoulder Calcific Tendinopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Ortopedico Rizzoli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Azienda Ospedaliera San Giovanni Battista</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Istituto Ortopedico Rizzoli</source>
  <oversight_info>
    <authority>Italy: The Italian Medicines Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy and effects on the
      hypothalamus-pituitary-adrenal axis of a single intrabursal injection of two different types
      of corticosteroids (methylprednisolone and triamcinolone) in patients with calcific shoulder
      tendinopathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rotator cuff calcific tendonitis is a common disease, mainly affecting women aged 30 to 50
      years old. It is associated to severe pain and impotence. US-guided percutaneous treatment
      is considered the gold standard treatment with the aim to destroy and wash out shoulder's
      calcification, responsible for inflammation, pain and functional limitation. Corticosteroids
      are injected in the subacromial-subdeltoid bursa at the end of the procedure to facilitate
      the prompt pain relief and functional recovery. Although corticosteroids represent the most
      powerful drugs to reduce inflammation and pain, their use is associated to important side
      effects, mainly the suppression of the hypothalamus-pituitary-axis (HPA). At the same time,
      no standardized protocols exist regarding the best type and dose of corticosteroid to be
      injected in association to the above mentioned treatment, nor data evaluating the exact
      duration of HPA suppression following a single intrabursal injection of corticosteroids.

      40 patients affected by rotator cuff calcific tendonitis will be enrolled in the study and
      randomly assigned to two groups: one group (20 patients) will be treated with a single
      intrabursal injection of 40 mg of methylprednisolone; the other group (20 patients) will be
      treated with a single intrabursal injection of 40 mg of triamcinolone.

      All patients will be tested at time 0 (morning before treatment) and at 1, 7, 15, 30 and 45
      days after the injection, using clinical, laboratory and US parameters in order to compare
      the efficacy and safety of the two drugs.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Degree of functional improvement</measure>
    <time_frame>0, 1, 7, 15, 30 and 45 days after treatment</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patients will be evaluated clinically (VAS and Constants scores) and by ultrasonography (residual calcification and bursa thickness)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Suppression of hypothalamus-pituitary-adrenal axis</measure>
    <time_frame>0, 1,7, 15, 30 and 45 days after treatment</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Evaluation of blood cortisol and ACTH, free urinary cortisol, urinary levels of methylprednisolone or triamcinolone (depending on the administered drug) by RIA immunoassay and tandem mass assays</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Rotatory Cuff Calcific Tendonitis</condition>
  <arm_group>
    <arm_group_label>methylprednisolone acetate group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single intrabursal injection of methylprednisolone acetate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Triamcinolone acetonide group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single intrabursal injection of Triamcinolone acetonide</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>methylprednisolone acetate</intervention_name>
    <description>Single intrabursal ultrasound guided injection</description>
    <arm_group_label>methylprednisolone acetate group</arm_group_label>
    <other_name>Depo-medrol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone Acetonide</intervention_name>
    <description>Single intrabursal ultrasound guided injection</description>
    <arm_group_label>Triamcinolone acetonide group</arm_group_label>
    <other_name>Triamvirgi</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  painful rotator cuff calcific tendonitis demonstrated by ultrasounds

        Exclusion Criteria:

          -  pregnancy

          -  use of corticosteroids in the previous 2 months

          -  systemic chronic inflammatory or allergic diseases

          -  allergy to methylprednisolone or triamcinolone

          -  diabetes

          -  glaucoma

          -  coagulopathies or current treatment with antiaggregants or anticoagulants

          -  septic arthritis or infections

          -  calcific enthesopathy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rizzoli Orthopaedic Institute</name>
      <address>
        <city>Bologna</city>
        <zip>40136</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://www.ior.it/curarsi-al-rizzoli/drssa-milva-battaglia</url>
    <description>Dr Battaglia's page on the website of Rizzoli Orthopedic Institute explaining her activity</description>
  </link>
  <reference>
    <citation>Serafini G, Sconfienza LM, Lacelli F, Silvestri E, Aliprandi A, Sardanelli F. Rotator cuff calcific tendonitis: short-term and 10-year outcomes after two-needle us-guided percutaneous treatment--nonrandomized controlled trial. Radiology. 2009 Jul;252(1):157-64. Erratum in: Radiology. 2010 Feb;254(2):636.</citation>
    <PMID>19561254</PMID>
  </reference>
  <reference>
    <citation>Uhthoff HK, Loehr JW. Calcific Tendinopathy of the Rotator Cuff: Pathogenesis, Diagnosis, and Management. J Am Acad Orthop Surg. 1997 Jul;5(4):183-191.</citation>
    <PMID>10797220</PMID>
  </reference>
  <reference>
    <citation>Krasner AS. Glucocorticoid-induced adrenal insufficiency. JAMA. 1999 Aug 18;282(7):671-6.</citation>
    <PMID>10517721</PMID>
  </reference>
  <reference>
    <citation>Spiegel RJ, Vigersky RA, Oliff AI, Echelberger CK, Bruton J, Poplack DG. Adrenal suppression after short-term corticosteroid therapy. Lancet. 1979 Mar 24;1(8117):630-3.</citation>
    <PMID>85870</PMID>
  </reference>
  <reference>
    <citation>Mader R, Lavi I, Luboshitzky R. Evaluation of the pituitary-adrenal axis function following single intraarticular injection of methylprednisolone. Arthritis Rheum. 2005 Mar;52(3):924-8.</citation>
    <PMID>15751089</PMID>
  </reference>
  <reference>
    <citation>Duclos M, Guinot M, Colsy M, Merle F, Baudot C, Corcuff JB, Lebouc Y. High risk of adrenal insufficiency after a single articular steroid injection in athletes. Med Sci Sports Exerc. 2007 Jul;39(7):1036-43.</citation>
    <PMID>17596769</PMID>
  </reference>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 11, 2013</lastchanged_date>
  <firstreceived_date>July 21, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istituto Ortopedico Rizzoli</investigator_affiliation>
    <investigator_full_name>milva.battaglia</investigator_full_name>
    <investigator_title>Clinician, Principal Investigator, Department of Radiology</investigator_title>
  </responsible_party>
  <keyword>rotatory cuff calcific tendonitis</keyword>
  <keyword>corticosteroids</keyword>
  <keyword>US guided percutaneous treatment</keyword>
  <keyword>methylprednisolone</keyword>
  <keyword>triamcinolone</keyword>
  <keyword>hypothalamus pituitary adrenal axis</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tendinopathy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
